Wells Fargo’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $129M | Buy |
|
|||||
|
2025
Q2 | $141M | Buy |
|
|||||
|
2025
Q1 | $149M | Buy |
|
|||||
|
2024
Q4 | $116M | Sell |
|
|||||
|
2024
Q3 | $198M | Buy |
|
|||||
|
2024
Q2 | $201M | Buy |
|
|||||
|
2024
Q1 | $187M | Buy |
|
|||||
|
2023
Q4 | $162M | Buy |
|
|||||
|
2023
Q3 | $144M | Sell |
|
|||||
|
2023
Q2 | $166M | Buy |
|
|||||
|
2023
Q1 | $168M | Sell |
|
|||||
|
2022
Q4 | $190M | Sell |
|
|||||
|
2022
Q3 | $172M | Buy |
|
|||||
|
2022
Q2 | $182M | Sell |
|
|||||
|
2022
Q1 | $222M | Buy |
|
|||||
|
2021
Q4 | $203M | Sell |
|
|||||
|
2021
Q3 | $227M | Sell |
|
|||||
|
2021
Q2 | $248M | Sell |
|
|||||
|
2021
Q1 | $256M | Sell |
|
|||||
|
2020
Q4 | $258M | Buy |
|
|||||
|
2020
Q3 | $200M | Sell |
|
|||||
|
2020
Q2 | $223M | Buy |
|
|||||
|
2020
Q1 | $184M | Sell |
|
|||||
|
2019
Q4 | $247M | Sell |
|
|||||
|
2019
Q3 | $239M | Buy |
|
|||||
|
2019
Q2 | $270M | Buy |
|
|||||
|
2019
Q1 | $216M | Buy |
|
|||||
|
2018
Q4 | $193M | Buy |
|
|||||
|
2018
Q3 | $200M | Sell |
|
|||||
|
2018
Q2 | $178M | Sell |
|
|||||
|
2018
Q1 | $189M | Sell |
|
|||||
|
2017
Q4 | $261M | Buy |
|
|||||
|
2017
Q3 | $161M | Buy |
|
|||||
|
2017
Q2 | $129M | Sell |
|
|||||
|
2017
Q1 | $137M | Buy |
|
|||||
|
2016
Q4 | $83.8M | Sell |
|
|||||
|
2016
Q3 | $77.5M | Sell |
|
|||||
|
2016
Q2 | $88.4M | Buy |
|
|||||
|
2016
Q1 | $87M | Sell |
|
|||||
|
2015
Q4 | $90.3M | Buy |
|
|||||
|
2015
Q3 | $81.2M | Sell |
|
|||||
|
2015
Q2 | $105M | Sell |
|
|||||
|
2015
Q1 | $102M | Buy |
|
|||||
|
2014
Q4 | $65.1M | Buy |
|
|||||
|
2014
Q3 | $60.9M | Sell |
|
|||||
|
2014
Q2 | $56.4M | Sell |
|
|||||
|
2014
Q1 | $52.7M | Buy |
|
|||||
|
2013
Q4 | $48M | Buy |
|
|||||
|
2013
Q3 | $43.1M | Buy |
|
|||||
|
2013
Q2 | $40.7M | Buy |
|